Tuesday, December 12, 2017 10:15 PM ET
Loxo Oncology (LOXO) Insiders Make Significant Share Sales Extending the Trend of Last Quarter
There was a significant level of insider selling revealed today in filings with the SEC for Loxo Oncology. Two insiders — OrbiMed Advisors Llc, Director, and David P Bonita, Director — sold 500,000 shares in the company for approximately $41,250,000. There have been 6 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the sale of 1,601,250 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 2,101,250 shares and have averaged 262,656 shares per transaction over this time period.
In relation to the peer group over the last 90 days, insider buy/sell trading at Loxo Oncology is greater than the 278-company peer group average. Bio Therapeutic Drugs peer group saw 337 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Loxo Oncology insiders was also higher. Within the peer group there were 37,864,912 shares purchased and 42,232,795 shares sold with company insiders disposing of 12,961 shares on average.
In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data sourced to evaluate and write this story.
Today’s Insider Activity
* OrbiMed Advisors Llc, Director, sold 250,000 shares
* David P Bonita, Director, sold 250,000 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.